The first of several spine injury patients is undergoing treatment, which has helped rodents regain the ability to walk and run. Doctors' hopes are high.
By Amina Khan, Los Angeles Times
October 12, 2010
Researchers announced Monday that they had injected stem cells into a patient with a spinal cord injury on Friday, kicking off the world's first clinical trial of a therapy derived from human embryonic stem cells.
The patient was treated at Shepherd Center, a spinal cord and brain injury center in Atlanta.
Though the trial, run by Geron Corp. of Menlo Park, Calif., is in its earliest stages — aimed primarily at testing the treatment for safety — the event stands as a landmark one for embryonic stem cell researchers, who for years have studied the cells' potential to treat spinal cord injuries, diabetes and a variety of neurodegenerative diseases.
"All of that work, all of that money sent to the ivory towers is manifesting something. It's a real shot in the arm for the field," said Hans Keirstead, a neurobiologist at the Reeve-Irvine Research Center at UC Irvine who led a team that pioneered the treatment in rats and licensed the technology to Geron.
more
http://www.latimes.com/health/la-sci-stem-cell-trial-20101012,0,362113.storyKeeping fingers crossed...